Viewing nowCombinationFlositadol 10/100 mg (Dapagliflozin, Sitagliptin)
Sitagliptin Phosphate Hydrate 128.5mg · Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication · Combination
Nexfarm Korea Co., Ltd.

MFDS item code 202300910 · Approved 2023.03.14 · Insurance code 662504850
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used as an adjunct to dietary and exercise therapy to help patients with type 2 diabetes manage their blood sugar levels. The combination of sitagliptin and dapagliflozin effectively improves blood glucose levels, providing assistance in diabetes management. This can serve as a beneficial treatment option for patients struggling with blood sugar control.
This medicine may be administered as 1 tablet once daily, with or without food, to patients receiving sitagliptin 100 mg and dapagliflozin 10 mg. The tablet should be swallowed whole. The efficacy and safety of this medicine depend on renal function. It is recommended that renal function be assessed before treatment with this medicine and periodically thereafter. No dose adjustment is necessary when the estimated glomerular filtration rate [estimated glomerular filtration rate (eGFR)] is 45 mL/min/1.73m2 or higher. This medicine should not be administered when the estimated glomerular filtration rate (eGFR) is less than 45 mL/min/1.73 m2. No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment.
This medication may cause allergic reactions due to the sitagliptin component, and in severe cases, it may lead to anaphylaxis or skin conditions. Therefore, if any abnormal symptoms occur within the first 3 months, patients should immediately discontinue use and consult a doctor. Additionally, sitagliptin can cause acute pancreatitis, so if symptoms of pancreatitis, such as abdominal pain or vomiting occur after taking this medication, discontinue use immediately and go to a hospital. This medication should not be used in patients with type 1 diabetes, diabetic ketoacidosis, or those undergoing dialysis. The dapagliflozin component may cause hypotension or renal function deterioration in patients with decreased fluid volume and kidney impairment. Therefore, it is essential to check fluid status and renal function before administration, and monitor for hypotensive symptoms and changes in renal function during the therapy. In patients with significantly impaired renal function, the blood sugar control effect of this medication may be reduced, and its use is not recommended in those with low renal function. If there is an allergy to the Yellow No. 5 component included in this medication, it should be used with caution. During treatment, genital infections or urinary tract infections may occur, and appropriate treatment should be sought if symptoms arise. There is a risk of hypoglycemia; therefore, caution is advised when taking this medication with other hypoglycemic agents such as insulin or sulfonylureas, and dosage adjustments of other medications may be necessary if needed. It is recommended that women who are pregnant or breastfeeding do not use this medication, especially during breastfeeding, as it may excrete into breast milk. Elderly patients or those with reduced renal function require dosage adjustments and renal function tests; they should be cautious due to an increased risk of hypotension from decreased fluid volume. In cases of overdose, there is no specific antidote, so appropriate treatment should be provided based on symptoms, and dialysis may be considered if necessary. Finally, the safety and efficacy of this medication in children have not been established; hence, it should not be used in patients under 18 years of age.
Severe hypersensitivity reactions, anaphylaxis, angioedema, Stevens-Johnson syndrome, acute pancreatitis, hemorrhagic pancreatitis, necrotizing pancreatitis, genital infections, vulvovaginitis, balanitis, urinary tract infections, fungal infections, perineal necrosis, hypoglycemia, decreased fluid volume, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, back pain, dysuria, polyuria, nocturia, vulvar pruritus, genital pruritus, increased hematocrit, reduced renal creatinine clearance, dyslipidemia, elevated serum creatinine, elevated blood urea, weight loss, rash, urosepsis, pyelonephritis, acute kidney injury, renal dysfunction, gastroesophageal reflux disease, upper abdominal pain, diverticulosis, intestinal perforation, chronic pancreatitis, hyperglycemia, paresthesia, cerebral infarction, nerve compression, severe joint pain associated with disability, blistering pemphigoid, myalgia, limb pain, back pain, interstitial lung disease, pruritus, thrombocytopenia, rhabdomyolysis, pneumonia, diabetic complications, metabolic acidosis, falls, cardiac arrest, sensory loss, headache, dyspepsia, nausea, diarrhea, vomiting, urinary retention, increased alanine aminotransferase, increased aspartate aminotransferase, decreased appetite, lethargy, palpitations, insomnia, fatty liver, gallbladder polyps, tinnitus, nasopharyngitis, upper respiratory infection, peripheral edema, itching, urticaria, cold sweat, joint pain, musculoskeletal pain, limb pain, muscle weakness, myalgia, osteoarthritis, ligament sprains, diabetic retinopathy, cough, dyspnea, orthostatic hypotension, anxiety disorders, enuresis, depression, hallucinations, sleep disorders, suicide attempts, biliary stones, cholangitis, alcoholic liver cirrhosis, liver cysts, dizziness, gastric adenocarcinoma, anal-genital warts, gastric adenoma, neuroma, pituitary neoplasm of unspecified type, male hypogonadism, thyroid cysts, thyroid nodules, food allergies, polycythemia
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius.
Yellow to orange, biconvex, round film-coated tablet
28 tablets / box [(7 tablets / PTP (Alu-Alu) x 4)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationSitagliptin Phosphate Hydrate 128.5mg · Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication · Combination
Nexfarm Korea Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Daewoo Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
International Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
IYON Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Kujoo Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.